Randomised trial of erythromycin on the development of chronic lung disease in preterm infants

AIMS—To determine if erythromycin given from birth reduces the inflammatory response and the incidence and severity of chronic lung disease.
METHODS—Seventy five infants less than 30 weeks of gestation and ventilated from birth for lung disease were randomly assigned to receive erythromycin intraven...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lyon, A, McColm, J, Middlemist, L, Fergusson, S, McIntosh, N, Ross, P
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 1998
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1720741/
https://ncbi.nlm.nih.gov/pubmed/9536833
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares